Ovintiv Inc. (OVV)

Negative net income growth while CRK stands at 89.40%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.

Well above CRK's 45.71% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.

Both reduce yoy usage, with CRK at -565.09%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.

Negative yoy usage while CRK is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.

Well above CRK's 72.48%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.

Negative yoy CFO while CRK is 5.37%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.

CapEx growth well above CRK's 59.38%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.

No Data available this quarter, please select a different quarter.

Growth well above CRK's 100.47%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.

Investing outflow well above CRK's 59.72%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.

No Data available this quarter, please select a different quarter.

Stock issuance far above CRK's 34.33%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.

Both yoy lines negative, with CRK at -54.94%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.